Dr. Navile Aditya Murali

Dr. Navile Aditya Murali
Medical Oncologist, Faridabad

MBBS, MD (Medicine), DM (Medical Oncology)

  • 1 Hospital


  • Languages :English, Hindi, Kannada, Tamil

Experience

Medical Oncology, Adyar Cancer Institute, Chennai

Medical Oncology, Madurai Medical College, Madurai

Specialities

  • Medical Oncology

  • Bone Marrow Transplant

  • Hemato Oncology

Conditions

  • Lung Cancer

Education

MBBS, Kasturba Meical College, India

MD (Medicine), Madurai Medical College, India

DM (Medical Oncology), Cancer Institute (WIA), India

Practice Information

Sarvodaya Hospital & Research Centre, Faridabad

Sarvodaya Hospital & Research Centre, Faridabad

YMCA Road, Sector-8, Near ESI Hospital, Sector-8, Faridabad, Haryana - 121005

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Navile Aditya Murali and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Murali N.A, Ganesan P, Vijaykumar V, Kannan K, Radhakrishnan V, Ganesan T.S, Sagar T.G. – Increasing incidence of multi-drug resistant Gram negative septicemia during induction therapy of acute myeloid leukemia. J Hosp Infect [Internet]. [cited 2016 May 9]; Available from: http://dx.doi.org/10.1016/j.jhin.2016.04.012.
  • Murali N.A, Rajendranath R, Ganesan P, Radhakrishnan V, Ganesan T.S, Sagar T.G. Outcomes in Small Cell  Lung cancer in India - A 15 year retrospective analysis. Poster presentation at the 16th World Lung Cancer Congress - 2015 Denver, USA.
  • Murali N.A, Ganesan P, Kannan K, Radhakrishnan V, Ganesan T.S, Sagar T.G. Outcomes in Multiple Myeloma - post high dose chemotherapy and autologous bone marrow transplantation at Cancer Institute. Poster presentation at HEMATOCON 2015 – Banglore
  • Murali N.A, Ganesan P, Vijaykumar V, Kannan K, Radhakrishnan V, Ganesan T.S, Sagar T.G. Carbapenem resistant MDR sepsis during induction chemotherapy in Acute Myeloid Leukemia - Outcome analysis at Cancer Institute. Poster presentation at HEMATOCON 2015 – Banglore-2005.
  • European Society of Medical Oncology
  • International Association for the study of Lung cancer